Histone Lactylation-mediated PKM2 promotes gemcitabine resistance in pancreatic adenocarcinoma via the AKT/mTOR/SREBP1 Axis. // Biochimica et Biophysica Acta: General Subjects. – URL: https://www.sciencedirect.com/science/article/pii/S0304416526000954?dgcid=rss_sd_all
Histone Lactylation-mediated PKM2 promotes gemcitabine resistance in pancreatic adenocarcinoma via the AKT/mTOR/SREBP1 Axis. Biochimica et Biophysica Acta: General Subjects. https://www.sciencedirect.com/science/article/pii/S0304416526000954?dgcid=rss_sd_all
“Histone Lactylation-mediated PKM2 promotes gemcitabine resistance in pancreatic adenocarcinoma via the AKT/mTOR/SREBP1 Axis.” Biochimica et Biophysica Acta: General Subjects.
@article{article1493,
title = {Histone Lactylation-mediated PKM2 promotes gemcitabine resistance in pancreatic adenocarcinoma via the AKT/mTOR/SREBP1 Axis},
journal = {Biochimica et Biophysica Acta: General Subjects},
url = {https://www.sciencedirect.com/science/article/pii/S0304416526000954?dgcid=rss_sd_all}
}